Corrigendum

This article refers to:

French contribution to develop Prussian blue

International Journal of Radiation Biology, November 2014; 90(11): 948–952

© 2014 Informa UK, Ltd.

ISSN 0955-3002 print / ISSN 1362-3095 online

DOI: 10.3109/09553002.2014.950714.

French contribution to develop Prussian blue Isabelle Besse Bardot, Sebastien Bardot, Florence Menetrier, Alexandra Leiterer & Annick Pech.

The publishers would like to apologise on behalf of the authors. Following the publication of an article in the International Journal of Radiation Biology, Volume 90, Issue (11) 948–952, we have been informed by the author of an error.

On page 952 the wrong table was submitted and subsequently included in the article.

The correct Table II follows.

Table II. Results of mutagenic assays.

Kind of assay	study OX1 2008
Ames assay	Prussian Blue didn’t induce mutagenical activity for 5 studied strains of salmonella typhimurium
Mouse lymphoma assay	In the experimental conditions Prussian Blue induced a moderated mutagenical activity without metabolic activation during a 24h continuous treatment and a low mutagenical activity with metabolic activation by TK mutation in vitro assay in mices’ L 5178Y lymphome cellulars
In vitro métaphase analysis in human lymphocyte	Without metabolic activation a significative genotoxic activity has been observed during two assays (4 hours of exposition followed by 16 hours period of recovery and 20 hours or 44 hours continuous hours of exposition)
	With metabolic activation, no genotoxic activity has been noted. A few increase of the cellulars’number with chromosomic aberrations has been observed but this effect has not been considered as a significant clastogenic effect